Am J Infect Control . Focused Multivector Ultraviolet (FMUV) Technology Rapidly Eradicates SARS-CoV-2 in-vitro: Implications for Hospital Disinfecti

[tetano]

Am J Infect Control


. 2022 Feb 10;S0196-6553(22)00065-7.
doi: 10.1016/j.ajic.2022.02.001. Online ahead of print.
Focused Multivector Ultraviolet (FMUV) Technology Rapidly Eradicates SARS-CoV-2 in-vitro: Implications for Hospital Disinfection of COVID-19 Environments


Steven Park[SUP] 1 [/SUP], David S Perlin[SUP] 1 [/SUP], Sean Fitzgerald[SUP] 1 [/SUP], Vidmantas Petraitis[SUP] 2 [/SUP], Thomas J Walsh[SUP] 3 [/SUP]



Affiliations

• PMID: 35151772
• DOI: 10.1016/j.ajic.2022.02.001

Abstract

Focused Multivector Ultraviolet (FMUV) technology rapidly killed the SARS-CoV-2 coronavirus in-vitro. Plates were inoculated with a mean of greater than 10[SUP]6[/SUP] plaque forming units (PFUs) of USA-WA1 Washington index patient strain of SARS-CoV-2 and exposed to ultraviolet, resulting in mean reductions of 99.99% within 30 seconds, 99.999% within 60 seconds, and 99.9999% within 90 seconds. The results support the effectiveness of FMUV technology for SARS-CoV-2 disinfection.

Keywords: COVID-19; FMUV; SARS-CoV-2; UV disinfection; disinfection; shadowless delivery.